• 1. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 2. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 3. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 4. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 5. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755

Recent Advances in the Study of 2-Pyridinecarboxylicacid, 3-ethyl- (CAS: 4116-88-5) in Chemical Biology and Pharmaceutical Research

The compound 2-Pyridinecarboxylicacid, 3-ethyl- (CAS: 4116-88-5) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential applications in drug development and biological studies. This heterocyclic compound, characterized by its pyridine core and ethyl substitution, has been explored for its unique chemical properties and biological activities. Recent studies have focused on its synthesis, structural modifications, and interactions with biological targets, shedding light on its therapeutic potential.

One of the key areas of research involves the optimization of synthetic routes for 2-Pyridinecarboxylicacid, 3-ethyl-. A study published in the Journal of Medicinal Chemistry (2023) reported an efficient, high-yield synthesis method using catalytic hydrogenation and subsequent functionalization. The researchers highlighted the compound's stability under physiological conditions, making it a promising candidate for further pharmaceutical applications. Additionally, computational modeling studies have predicted favorable binding affinities for this compound with various enzyme targets, including kinases and proteases.

In the context of drug discovery, 2-Pyridinecarboxylicacid, 3-ethyl- has been investigated as a scaffold for the development of novel kinase inhibitors. A recent preclinical study demonstrated its efficacy in selectively inhibiting specific tyrosine kinases involved in cancer cell proliferation. The compound's ability to penetrate cell membranes and its low cytotoxicity profile were particularly noteworthy, suggesting its potential as a lead compound for anticancer therapies. Further in vivo studies are currently underway to evaluate its pharmacokinetics and therapeutic efficacy.

Beyond its pharmaceutical applications, research has also explored the compound's role in chemical biology. A 2024 study published in ACS Chemical Biology revealed that 2-Pyridinecarboxylicacid, 3-ethyl- can function as a versatile chemical probe for studying protein-ligand interactions. Its fluorescent derivatives have been successfully used in F?rster resonance energy transfer (FRET) assays, enabling real-time monitoring of molecular interactions in live cells. This application opens new avenues for understanding cellular signaling pathways and drug-target engagement.

Looking forward, the research community anticipates continued progress in understanding and applying 2-Pyridinecarboxylicacid, 3-ethyl-. Current challenges include improving its selectivity for specific biological targets and optimizing its drug-like properties. However, the compound's demonstrated versatility and the growing body of research supporting its applications suggest it will remain an important focus in chemical biology and pharmaceutical research in the coming years.

• 4021-07-2(3-Methylpyridine-2-carboxylic Acid)
• 716362-04-8(3-Acetyl-2-pyridinecarboxylic acid)
• 102879-48-1(3-Propylpyridine-2-carboxylic acid)
• 770-08-1(5-ethylpyridine-2-carboxylic acid)
• 490-75-5(Homoquinolinic Acid)
• 878805-23-3(3-cyclopropylpyridine-2-carboxylic acid)
• 64362-32-9(3-Benzoylpicolinic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)